OpenAI kills Sora

OpenAI abruptly shut down Sora — its AI video product — despite a prior $1.0B Disney investment and exclusive character deal, citing a refocus on core products and potential cost, legal and reputational risks. Arm said it will build and sell an 'Arm AGI CPU' for data-center AI with Meta, signaling a move from pure IP licensing into competitive silicon; Apple will begin selling ads in Maps in the U.S. and Canada this summer and launch a consolidated Apple Business platform in 200 countries on April 14. A jury awarded plaintiffs roughly $375M in a major child-safety suit against Meta (appeal expected); SpaceX may file for an IPO as soon as this week; and Epic plans to cut about 1,000 jobs.

Analysis

The sudden retrenchment from ultra-high‑compute consumer-facing generative video products underscores a simple economic reality: per‑unit compute and energy costs for photoreal motion generation remain uncoupled from reliable ARPU pathways. Expect cloud GPU demand growth to bifurcate — short‑cycle inference and fine‑tuning workloads that pay per‑use versus long, loss‑making content generation workflows that get shelved or forced behind premium B2B contracts. This will favor companies that can compress FLOPs per frame (software / compiler sellers) and hyperscalers that can monetize reserved capacity with enterprise SLAs within 6–18 months.

A chip‑IP licensor moving toward captive silicon creates a classic principal–agent upset that will ripple across OEM roadmaps and foundry allocations. Large licensees will accelerate either (a) vertical in‑house cores or extensions, (b) migration to multi‑ISA heterogenous stacks, or (c) push for preferential licensing terms — all of which can compress royalty growth and reprice peers’ moats over 12–36 months. Foundries and packaging suppliers are the second‑order beneficiaries if bespoke AI centric dies proliferate, but expect legal and counterpart friction as incumbents negotiate coexistence clauses.

Separately, expansion of device‑centric ad inventory that preserves first‑party privacy signals raises ad revenue per device without reopening mass data sharing; that structural ARPU lift should be visible in quarterly guidance within two reporting cycles. Conversely, enlarging litigation envelopes for social platforms is increasing tail liability and insurance costs — a near‑term volatility driver that can force multiple contraction even if cash flow holds. Key catalysts to watch: enterprise contract wins for efficient model stacks, licensee responses and regulatory inquiries around chip licensing, and upcoming ad/earnings prints that reveal monetization slopes.

Key Decisions for Investors

• Buy ARM (ARM) 12–18 month LEAP calls sized 2–3% net exposure of portfolio: asymmetric upside if the firm successfully monetizes a niche data‑centre CPU; cap premium paid to limit downside to ~100% of premium. Target 30–50% IRR if licensing confusion resolves, stop‑loss: 40% of premium.
• Long AAPL equity or buy a 3–6 month call spread (moderate size): capture non‑advertising high‑margin ad upside and enterprise services lift. Risk/reward: pay ~1x premium for a 10–15% upside target into next two quarters; trim on >15% move.
• Buy protective puts on META (META) – 3 month, ~15–25% OTM — small hedge (0.5–1% portfolio) to guard against additional litigation/regulatory shocks that could compress multiples. Cost is insurance; payoff asymmetric if another adverse verdict or regulatory action emerges within 90 days.
• Pair trade for tactical alpha: Long ARM (equity or calls) / Short NVDA (size ~0.5x NVDA notional) for 12 months — rationale: capture re‑rating of a new‑entrant IP vendor while shorting a high multiple incumbent that faces incremental competition and potential pricing pressure. Keep pair delta‑neutral to market; hard stop if ARM execution materially falters or NVDA reports accelerating demand (cut loss at 15% portfolio move).